Tumor Necrosis Factor and Interleukin 1 Appearance in Experimental Gram-negative Septic Shock
- 1 May 1991
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Surgery
- Vol. 126 (5) , 591-597
- https://doi.org/10.1001/archsurg.1991.01410290067014
Abstract
• To study the effect of plasma removal vs plasma administration on the appearance of tumor necrosis factor (TNF) and interleukin 1 in septic shock, 24 anesthetized piglets were inoculated with live Escherichia coli. Plasma exchange with albumin was performed in one group. Fresh-frozen plasma was administered to a second group. A third group served as nontreated controls. Following plasma exchange, a reduction in both TNF and interleukin 1 levels occurred, whereas plasma infusion was followed by a decrease in TNF levels only. No significant differences were observed between the two treated groups with respect to survival or cardiovascular performance, with both being significantly enhanced compared with the controls. High levels of TNF and interleukin 1 correlated with depressed cardiovascular performance in the early phase of the shock. Our results confirm the important role of TNF and interleukin 1 as early mediators of septic shock. However, the benefit of reducing cytokine activity in later stages of septicemia seems to be dubious. (Arch Surg. 1991;126:591-597)Keywords
This publication has 12 references indexed in Scilit:
- Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.Journal of Clinical Investigation, 1988
- New Concepts on the Pathogenesis of FeverClinical Infectious Diseases, 1988
- Production and clearance of tumor necrosis factor in rats exposed to endotoxin and dexamethasoneClinical Immunology and Immunopathology, 1987
- A simple sensitive bioassay for interleukin-1 which is unresponsive to 103 U/ml of interleukin-2Journal of Immunological Methods, 1987
- A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytesJournal of Immunological Methods, 1986
- Interleukin 1 induces endothelial cell synthesis of plasminogen activator inhibitor.The Journal of Experimental Medicine, 1986
- Modulation of endothelial cell hemostatic properties by tumor necrosis factor.The Journal of Experimental Medicine, 1986
- Passive Immunization Against Cachectin/Tumor Necrosis Factor Protects Mice from Lethal Effect of EndotoxinScience, 1985
- Studies of conditions and agents that stimulate and inhibit the production of cachectin by macrophagesPublished by Springer Nature ,1984
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983